4//SEC Filing
D'Onofrio Matthew J 4
Accession 0001209191-22-007263
CIK 0001403708other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:23 PM ET
Size
5.5 KB
Accession
0001209191-22-007263
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
D'Onofrio Matthew J
Exec VP, Chief Bus. Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-02+100,000→ 100,000 totalExercise: $0.55Exp: 2032-02-01→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option shall vest at the rate of 1/48th of the original number of shares on each monthly anniversary of January 1, 2022, subject to the reporting person's continuous service to the issuer on each such vesting date.
Documents
Issuer
Evoke Pharma Inc
CIK 0001403708
Entity typeother
Related Parties
1- filerCIK 0001578770
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 5:23 PM ET
- Size
- 5.5 KB